ValitaCell attend Bioprocessing Summit Boston

ValitaCell attend Bioprocessing Summit Boston 2022

We’ve enjoyed unprecedented growth in the US market so we were delighted to meet our current and new customers at the 14th annual Bioprocessing Summit in Boston from August 15th to 18th. The conference itself included seven streams and a range of training seminars across three days. We’ve found attendees at physical conferences to be extremely engaged having not been able to enjoy face-to-face contact for over two years.

The conference featured several educational and inspiring speakers including Dr. Nicholas Warne, Vice president of pharmaceutical research and development at Pfizer. His presentation on ‘lessons learned from the pandemic’ was eye opening and inspiring. His presentation outlined the approach taken by Pfizer, with their partner BioNTech, in the development, manufacture, and distribution of the Covid-19 vaccine drug product while reflecting on lessons that may, or may not, be applicable to future product development.

With each new conference, we learn more about our customer’s specific analytical needs and it’s been wonderful to now introduce our customers to a fully relaunched ChemStress®, CellAi® and of course our flagship product, Valita®Titer.


Bioprocessing Summit BostonPresentation streams – Bioprocessing Summit Boston 

ValitaCell at Bioprocessing Summit Boston

Dr. Alessandra Prinelli, Technical Product Manager & Brian Murphy, Commercial Director 

Want to talk about our products?

Hi, I’m Eligio, Business Development Manager at ValitaCell. Fill in the form to the right and I’ll get in touch with you soon!

    I agree to receive marketing communication from ValitaCell by e-mail

    The controller of your personal data is ValitaCell. We process your personal data in order to respond to your questions and for sending marketing communication, if you agreed. You have the right to access data, the right to request rectification, deletion or limitation of their processing, data transfer, the right to object, as well as the right to lodge a complaint to the supervisory body. Full information about processing of personal data can be found in the Privacy Policy.

    Show More